NEW YORK (GenomeWeb) – MetaStat said yesterday that it has raised $3.4 million through a Series B preferred stock private placement.

According to the firm, certain board members and management participated in the offering. H.C. Wainwright & Co., was the lead placement agent, while Alere Financial Partners, a division of Clancy Financial Services, was the co-placement agent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.